Antibody System Human IL6 ELISA Kit
Overview
This enzyme-linked immunosorbent assay (ELISA) kit is engineered for the ultra-sensitive quantitative determination of Human Interleukin-6 (IL-6) concentrations in serum, plasma, and cell culture supernatant samples. Interleukin-6 is a pleiotropic, 21–28 kDa phosphorylated and glycosylated cytokine produced by a wide variety of cell types, including monocytes, macrophages, T cells, fibroblasts, and endothelial cells. Mechanistically, IL-6 binds to its transmembrane or soluble receptor (IL-6R) to trigger gp130 homodimerization, activating downstream JAK/STAT and MAPK signaling pathways. It plays an essential role in driving the acute-phase response, stimulating B-cell differentiation, regulating T-cell balance, and controlling hematopoiesis. Elevated levels of circulating IL-6 serve as a paramount biomarker for systemic inflammation, cytokine release syndrome (CRS), autoimmune pathologies (such as rheumatoid arthritis), and oncology-associated immune dynamics. This high-performance sandwich lantha system provides an essential analytical platform for immunology researchers, clinical trial laboratories, and biomanufacturers tracking early inflammatory signaling metrics, host immune defenses, and therapeutic drug interventions.
PRODUCT INFO
Principle of the Assay
This assay utilizes a high-performance, solid-phase quantitative sandwich enzyme immunoassay technique to measure target protein levels:
-
Target Capture: A monoclonal antibody specific for Human IL-6 has been uniformly pre-coated onto the solid-phase surface of a 96-well microplate.
-
Specific Binding: Calibrated standards or unknown biological samples are pipetted directly into the microwells. Any endogenous Human IL-6 present in the sample matrix is securely bound and immobilized by the solid-phase capture antibody.
-
Sandwich Conjugation: Unbound matrix elements are removed via a thorough wash cycle. A biotin-labeled secondary antibody specific for Human IL-6 is introduced into the wells, anchoring onto an alternative epitope of the captured IL-6 target to establish a stable sandwich complex.
-
Enzyme Complexing: Following another wash step to clear away unbound detection antibody, Streptavidin conjugated to Horseradish Peroxidase (Streptavidin-HRP) is introduced to bind specifically to the biotinylated domains.
-
Signal Amplification and Readout: After a final wash to remove excess enzyme reagent, a colorimetric substrate solution is added to initiate enzymatic signal development. Because this is a traditional sandwich format, the resulting color intensity develops in direct proportion to the concentration of Human IL-6 bound in the initial step. The reaction is terminated with a stop solution, and absorbance is quantified spectrophotometrically.
Key Features and Performance Metrics
-
Ultra-Sensitive Detection Capability: Exhibits an elite analytical sensitivity down to 0.92 pg/mL, facilitating the accurate tracking of trace-level IL-6 concentrations.
-
Refined Quantitative Range: Delivers a precise linear tracking range from 4.69 pg/mL to 300 pg/mL, optimized for high-resolution cytokine profiling.
-
Rigorous Recovery Metrics: Validated with a target recovery range between 80 percent and 120 percent, indicating minimal matrix interference across verified human sample matrices.
-
Exceptional Precision Profile:
-
Intra-Assay Precision (Precision within an assay): <10% Coefficient of Variation (CV). Validated across three reference samples evaluated sixteen times on a single plate:
-
Sample 1: Mean = 158.0 pg/mL, SD = 13.3, CV = 8.4%
-
Sample 2: Mean = 36.3 pg/mL, SD = 3.4, CV = 9.4%
-
Sample 3: Mean = 9.0 pg/mL, SD = 0.5, CV = 5.9%
-
-
Inter-Assay Precision (Precision between assays): <15% Coefficient of Variation (CV). Verified across three independent samples tested in twenty-four separate runs:
-
Sample 1: Mean = 153.5 pg/mL, SD = 16.6, CV = 10.8%
-
Sample 2: Mean = 34.1 pg/mL, SD = 3.3, CV = 9.7%
-
Sample 3: Mean = 8.9 pg/mL, SD = 1.0, CV = 10.7%
-
-
Technical Specifications
-
Catalog No.: KHC15801
-
Assay Configuration: Quantitative Sandwich Enzyme Immunoassay
-
Targeted Biomarker: Human Interleukin-6 (IL-6)
-
Validated Matrices: Serum, Plasma, and Cell Culture Supernatant
-
Detection Method: Colorimetric
-
Assay Range: 4.69 to 300 pg/mL
-
Analytical Sensitivity: 0.92 pg/mL
-
Solid-Phase Target: Anti-Human IL-6 Specific Antibody
-
Detection Secondary Layer: Biotin-Anti-Human IL-6 / Streptavidin-HRP Conjugate
Applications and Workflow Summary
This sandwich ELISA platform is highly optimized for high-throughput cytokine tracking, acute-phase response monitoring, and systemic inflammation profiling. Investigators should observe the following guidelines:
-
Dilution and Layout: Unknown serum, plasma, or supernatant matrices must be screened alongside the provided reference standards. Samples exhibiting target concentrations exceeding the maximum range of 300 pg/mL must be diluted empirically in standard assay matrix buffer prior to running the assay.
-
Analysis Requirements: To achieve absolute quantification accuracy, investigators must generate a standard curve simultaneously during every plate run, plotting standard absorbance profiles against log-transformed concentration values.
Handling, Stability and Storage
-
Kit Shipping: Distributed under secure, temperature-controlled conditions between 2 and 8 degrees Celsius to safeguard protein matrix and enzyme binding configurations.
-
Operational Shelf Life: Built with high-grade components to guarantee consistent, low-decay signal retention, demonstrating an activity loss rate of less than 10 percent prior to the expiration date when kept under appropriate storage conditions.
-
Storage Guidance: Keep the complete kit stored strictly at the recommended refrigeration temperature upon receipt. Ensure that unused microplate wells remain sealed within their original desiccant pouch to guard against moisture compromise.
-

















